BaricitinibHerpes zoster, rebound effect in the form of flare of granuloma annulare and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1977卷 / 1期

关键词：

D O I：

10.1007/s40278-023-47144-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：70 / 70

相关论文

共 50 条

[21] LinezolidLeukopenia and off-label use: case report
Reactions Weekly, 2025, 2044 (1) : 180 - 180
[22] IbrutinibNeutropenia and off-label use: case report
Reactions Weekly, 2020, 1787 (1) : 271 - 271
[23] AntineoplasticsPancytopenia and off-label use: case report
Reactions Weekly, 2020, 1825 (1) : 39 - 39
[24] DexmedetomidineHypotension and off-label use: case report
Reactions Weekly, 2019, 1749 (1) : 172 - 172
[25] AzithromycinCardiotoxicity and Off-label use: case report
Reactions Weekly, 2023, 1953 (1) : 100 - 100
[26] RituximabCellulitis and off-label use: case report
Reactions Weekly, 2022, 1911 (1) : 363 - 363
[27] MirtazapineOtotoxicity and off-label use: case report
Reactions Weekly, 2024, 2037 (1) : 255 - 255
[28] Caplacizumab/prednisoneLack of drug effect and off-label use: case report
Reactions Weekly, 2021, 1867 (1) : 104 - 104
[29] Methylprednisolone/tocilizumabLack of drug effect and off-label use: case report
Reactions Weekly, 2022, 1914 (1) : 293 - 293
[30] Dasatinib/eltrombopag/imatinibThrombocytopenia and rebound effect in the form of worsening of thrombocytopenia following off label use: case report
Reactions Weekly, 2023, 1970 (1) : 110 - 110

← 1 2 3 4 5 →